Catyalyst Pharma (CPRX) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $15.34 -4.13%
Revenue Growth %: +16.4%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
ESCA, LICT, NKSH, More
Revenue Growth %: +16.4%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Glacier Bancorp (GBCI) Misses Q1 EPS by 3c
- Provident Financial Services (PFS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
